Report - IOLOGIS IN MODERATE TO SEVERE ROHN’S … American journal of gastroenterology 104, ... Ustekinumab Maintenance Therapy in Subjects with Moderately to Severely Active Crohn's Disease

Please pass captcha verification before submit form